Module 31 · Special populations

Paediatric emergencies essentials

NewPhase 3

What an adult ICU resident needs when a sick child arrives: paediatric resuscitation and weight-based doses, sepsis and fluids, airway sizes and ventilation, bronchiolitis and croup, DKA, and safe transfer to a PICU — with worked doses for 10–20 kg children and Indian context.

6 topics

Drugs in this module

Doses written for this module's context. The same drug may read differently in another module.

Adrenaline (epinephrine) — paediatric

Catecholamine (alpha + beta agonist)

Indications
Cardiac arrest; anaphylaxis; fluid-refractory (cold) septic shock; moderate–severe croup (nebulised); symptomatic bradycardia
Adult dose
Paediatric doses: arrest 0.01 mg/kg IV/IO (= 0.1 mL/kg of 0.1 mg/mL), max 1 mg, every 3–5 min. Anaphylaxis 0.01 mg/kg IM of 1 mg/mL (max 0.5 mg). Infusion 0.05–1 mcg/kg/min. Croup: nebulised 0.5 mL/kg of 1 mg/mL (max 5 mL).
Preparation (India)
1 mg/mL (1:1000) 1 mL ampoules. Make 0.1 mg/mL by diluting 1 mL in 9 mL NS. Infusion e.g. 0.3 mg/kg in 50 mL: 1 mL/h = 0.1 mcg/kg/min.
Cautions
Confusing 1 mg/mL with 0.1 mg/mL causes 10-fold errors — label syringes. Extravasation risk if given peripherally undiluted.
Monitoring
ECG, BP, perfusion, lactate, glucose.

Amiodarone — paediatric

Class III antiarrhythmic

Indications
Shock-refractory VF/pulseless VT; perfusing wide-complex or refractory SVT (with expert advice)
Adult dose
Arrest: 5 mg/kg IV/IO bolus (max 300 mg), may repeat up to a total of 15 mg/kg. Perfusing tachycardia: 5 mg/kg over 20–60 min.
Preparation (India)
150 mg/3 mL ampoule; dilute in D5W.
Cautions
Hypotension, bradycardia, QT prolongation; avoid combining with other QT-prolonging drugs without expert input.
Monitoring
ECG, BP.

Lidocaine (lignocaine) — paediatric

Class Ib antiarrhythmic

Indications
Shock-refractory VF/pVT (alternative to amiodarone)
Adult dose
1 mg/kg IV/IO bolus; infusion 20–50 mcg/kg/min.
Preparation (India)
2% (20 mg/mL) preservative-free for IV use.
Cautions
Seizures and myocardial depression with toxicity.
Monitoring
ECG, neurological status.

Adenosine — paediatric

Purinergic AV-nodal blocker

Indications
SVT with a pulse after vagal manoeuvres
Adult dose
0.1 mg/kg rapid IV push (max 6 mg) with immediate saline flush; second dose 0.2 mg/kg (max 12 mg).
Preparation (India)
3 mg/mL, 2 mL vials.
Cautions
Give through a large proximal vein with a two-syringe/three-way-tap flush; transient asystole; bronchospasm in asthma.
Monitoring
Continuous ECG recording during the dose.

Atropine — paediatric

Antimuscarinic

Indications
Bradycardia from increased vagal tone or primary AV block; selected intubations at risk of bradycardia
Adult dose
0.02 mg/kg IV/IO (max single dose 0.5 mg); may repeat once.
Preparation (India)
0.6 mg/mL ampoules.
Cautions
Not a substitute for oxygenation/ventilation in hypoxic bradycardia (commonest cause in children).

Dextrose 10% — paediatric

Carbohydrate

Indications
Hypoglycaemia in children (check glucose in every sick child)
Adult dose
2–5 mL/kg of 10% dextrose IV/IO (0.2–0.5 g/kg); recheck glucose in 15–30 min; then maintenance dextrose.
Preparation (India)
10% dextrose bags; to make from 25%: 2 parts 25% + 3 parts water/NS (approx. 10%).
Cautions
Avoid 25–50% dextrose peripherally in small children (vein injury); avoid hyperglycaemia.

Calcium chloride / calcium gluconate — paediatric

Electrolyte

Indications
Documented hypocalcaemia, hyperkalaemia, calcium-channel blocker toxicity (not routine in arrest)
Adult dose
Calcium chloride 10%: 20 mg/kg (0.2 mL/kg) IV/IO slowly (max 1 g). Calcium gluconate 10%: 60 mg/kg (0.6 mL/kg) IV/IO slowly (max 3 g).
Preparation (India)
Calcium gluconate 10% 10 mL ampoules are the usual Indian presentation; calcium chloride less widely stocked.
Cautions
Severe tissue injury if extravasated (especially chloride); not routine in cardiac arrest (2025 PALS).

Sodium bicarbonate — paediatric

Alkalinising agent

Indications
Hyperkalaemia, sodium-channel blocker (TCA) toxicity; not routine in arrest
Adult dose
1 mEq/kg slow IV/IO (8.4% = 1 mEq/mL; dilute 1:1 in infants).
Cautions
Not recommended routinely in paediatric arrest; flush line before catecholamines (inactivation).

Balanced crystalloid / 0.9% saline bolus — paediatric

IV fluid

Indications
Septic shock and hypovolaemia
Adult dose
10–20 mL/kg over 5–20 min, reassess after each bolus; up to 40–60 mL/kg in the first hour where intensive care is available, stopping at signs of fluid overload (crackles, hepatomegaly, rising work of breathing). Balanced crystalloid (Ringer's lactate) suggested over 0.9% saline.
Preparation (India)
Ringer's lactate and 0.9% saline widely available; use 50 mL syringes 'push-pull' for small children.
Cautions
Without intensive care and without hypotension, SSC suggests no bolus (maintenance fluids instead). Severe acute malnutrition: use smaller, slower volumes (WHO).
Monitoring
HR, capillary refill, BP, liver span, crackles, urine output, lactate.

Noradrenaline (norepinephrine) — paediatric

Alpha-1 > beta-1 agonist

Indications
Warm (vasodilated) septic shock after fluids
Adult dose
0.05–1 mcg/kg/min IV infusion, titrated to perfusion and age-appropriate MAP.
Preparation (India)
Common paediatric 'rule of 0.3': 0.3 mg/kg in 50 mL; 1 mL/h = 0.1 mcg/kg/min.
Cautions
May start through a good peripheral line in dilute form while central access is obtained (SSC).

Ceftriaxone — paediatric

Third-generation cephalosporin

Indications
Empirical antibiotic for community-acquired sepsis/meningitis beyond the neonatal period
Adult dose
Sepsis: 50–80 mg/kg IV once daily (max 2 g). Meningitis: 100 mg/kg/day IV in 1–2 doses (max 4 g/day). Give within 1 h of recognising septic shock.
Preparation (India)
250 mg, 500 mg, 1 g vials.
Cautions
Avoid in neonates with hyperbilirubinaemia and with calcium-containing IV fluids in neonates.

Hydrocortisone — paediatric

Glucocorticoid

Indications
Catecholamine-resistant septic shock with suspected adrenal insufficiency; known adrenal insufficiency/chronic steroid use
Adult dose
Commonly 2 mg/kg IV bolus (max 100 mg), then 1 mg/kg 6-hourly (max 50 mg/dose) or 50–100 mg/m²/day.
Preparation (India)
100 mg vials.
Cautions
SSC suggests against routine use when fluids and vasopressors restore stability.

Ketamine — paediatric

NMDA antagonist (dissociative anaesthetic)

Indications
Induction for intubation in shocked or asthmatic children; procedural sedation
Adult dose
Induction 1–2 mg/kg IV (reduce to 0.5–1 mg/kg in profound shock); IM 4–5 mg/kg if no access.
Preparation (India)
50 mg/mL vials (10 mL); dilute to 10 mg/mL for children.
Cautions
Laryngospasm and hypersalivation (rare); may still drop BP in catecholamine-depleted shock.

Rocuronium — paediatric

Non-depolarising neuromuscular blocker

Indications
Rapid sequence intubation
Adult dose
1–1.2 mg/kg IV.
Preparation (India)
10 mg/mL (5 mL vials); refrigerate.
Cautions
Only after airway plan and failed-airway backup are ready; sugammadex availability varies.

Fentanyl — paediatric

Opioid analgesic

Indications
Analgesia/blunting response at intubation; post-intubation analgesia
Adult dose
1–2 mcg/kg IV slowly; infusion 1–4 mcg/kg/h.
Preparation (India)
50 mcg/mL ampoules.
Cautions
Chest wall rigidity with rapid large doses (infants); hypotension; apnoea.

Dexamethasone (croup)

Glucocorticoid

Indications
Croup (all severities)
Adult dose
0.15–0.6 mg/kg PO (or IM/IV) single dose; 0.15 mg/kg is effective for mild–moderate croup; 0.6 mg/kg (max about 10–16 mg) often used for severe croup.
Preparation (India)
0.5 mg tablets; 4 mg/mL injection can be given orally mixed in syrup.
Cautions
Single dose is usually enough.

Budesonide (nebulised)

Inhaled glucocorticoid

Indications
Croup when oral route is not tolerated
Adult dose
2 mg nebulised single dose.
Preparation (India)
0.5 mg/2 mL respules (use 4 respules = 2 mg).

Regular (soluble) insulin — paediatric DKA

Insulin

Indications
Paediatric DKA
Adult dose
0.05–0.1 unit/kg/h IV infusion, started at least 1 h after starting fluid replacement; NO bolus.
Preparation (India)
100 units/mL vials; 50 units in 50 mL NS = 1 unit/mL (prime the line).
Cautions
Hypokalaemia and hypoglycaemia; start only once K⁺ ≥3.5 mmol/L (ISPAD) or with K⁺ replacement running.
Monitoring
Hourly glucose, 2–4-hourly electrolytes/blood gas, hourly neuro observations.

Potassium chloride (in IV fluids) — paediatric DKA

Electrolyte

Indications
Potassium replacement in DKA
Adult dose
Usually 40 mmol/L in rehydration fluid (20 mmol/L if fluid rate >10 mL/kg/h); start with initial volume expansion if hypokalaemic, with insulin if normokalaemic, and after urine output if hyperkalaemic. Keep within 0.5 mmol/kg/h.
Preparation (India)
15% KCl = 2 mmol/mL (10 mL ampoule = 20 mmol); premixed bags preferred to avoid errors.
Cautions
Never give KCl as an IV bolus; mix bags thoroughly.

Mannitol — paediatric

Osmotic diuretic

Indications
Cerebral oedema in DKA (or raised ICP)
Adult dose
0.5–1 g/kg IV over 10–15 min; may repeat after 30 min if no response.
Preparation (India)
20% mannitol (200 mg/mL): 0.5–1 g/kg = 2.5–5 mL/kg.
Cautions
Diuresis and hypovolaemia; crystallises if cold.

Hypertonic saline 3% — paediatric

Osmotic agent

Indications
Cerebral oedema in DKA (alternative to mannitol)
Adult dose
2.5–5 mL/kg of 3% NaCl IV over 10–15 min.
Preparation (India)
3% NaCl bags available in most Indian hospitals; can be prepared from 0.9% saline + 15% or 23.4% NaCl per pharmacy protocol.
Cautions
Hypernatraemia, hyperchloraemic acidosis.

Module references (19)

  1. 1

    Lasa JJ, Dhillon GS, Duff JP, et al. Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2025;152(16 suppl 2):S479-S537.

  2. 2

    Topjian AA, Raymond TT, Atkins D, et al. Part 4: Pediatric Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16 suppl 2):S469-S523.

  3. 3

    Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med. 2020;21(2):e52-e106.

  4. 4

    Schlapbach LJ, Watson RS, Sorce LR, et al. International Consensus Criteria for Pediatric Sepsis and Septic Shock (Phoenix criteria). JAMA. 2024;331(8):665-674.

  5. 5

    Maitland K, Kiguli S, Opoka RO, et al. Mortality after Fluid Bolus in African Children with Severe Infection (FEAST). N Engl J Med. 2011;364(26):2483-2495.

  6. 6

    World Health Organization. Updated guideline: paediatric emergency triage, assessment and treatment (ETAT). Geneva: WHO; 2016.

  7. 7

    World Health Organization. Pocket book of hospital care for children: guidelines for the management of common childhood illnesses. 2nd ed. Geneva: WHO; 2013.

  8. 8

    Glaser N, Fritsch M, Priyambada L, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23(7):835-856.

  9. 9

    Kuppermann N, Ghetti S, Schunk JE, et al. Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis (PECARN FLUID). N Engl J Med. 2018;378(24):2275-2287.

  10. 10

    Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis. Pediatrics. 2014;134(5):e1474-e1502.

  11. 11

    National Institute for Health and Care Excellence. Bronchiolitis in children: diagnosis and management (NG9). 2015, updated 2021.

  12. 12

    Franklin D, Babl FE, Schlapbach LJ, et al. A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis (PARIS). N Engl J Med. 2018;378(12):1121-1131.

  13. 13

    Gates A, Gates M, Vandermeer B, et al. Glucocorticoids for croup in children. Cochrane Database Syst Rev. 2018;8:CD001955.

  14. 14

    Bjornson CL, Klassen TP, Williamson J, et al. A Randomized Trial of a Single Dose of Oral Dexamethasone for Mild Croup. N Engl J Med. 2004;351(13):1306-1313.

  15. 15

    Emeriaud G, López-Fernández YM, Iyer NP, et al. Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2). Pediatr Crit Care Med. 2023;24(2):143-168.

  16. 16

    Luscombe M, Owens B. Weight estimation in resuscitation: is the current formula still valid? Arch Dis Child. 2007;92(5):412-415.

  17. 17

    Weiss M, Dullenkopf A, Fischer JE, et al. Prospective randomized controlled multi-centre trial of cuffed or uncuffed endotracheal tubes in small children. Br J Anaesth. 2009;103(6):867-873.

  18. 18

    Zirpe KG, Tiwari AM, Kulkarni AP, et al. Position Statement of ISCCM on Intrahospital Transport of Critically Ill Patients. Indian J Crit Care Med. 2025;29(4):291-300.

  19. 19

    Warren J, Fromm RE Jr, Orr RA, et al. Guidelines for the inter- and intrahospital transport of critically ill patients. Crit Care Med. 2004;32(1):256-262.